CM
Capula Management Portfolio holdings
AUM
$8.15B
This Quarter Return
-3.55%
1 Year Return
+15.35%
3 Year Return
+44.08%
5 Year Return
+48.51%
10 Year Return
–
AUM
$13.5B
AUM Growth
+$13.5B
(-7.4%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
89%
Holding
468
New
221
Increased
97
Reduced
54
Closed
87
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$8.64B |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
$295M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$160M |
| 4 |
Uber
UBER
|
$149M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$121M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$8.91B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$459M |
| 3 |
NVIDIA
NVDA
|
$290M |
| 4 |
CrowdStrike
CRWD
|
$208M |
| 5 |
Chevron
CVX
|
$93.9M |
Sector Composition
| 1 | Technology | 11.74% |
| 2 | Financials | 1.66% |
| 3 | Communication Services | 1.32% |
| 4 | Industrials | 1.15% |
| 5 | Consumer Discretionary | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATYR
351
aTyr Pharma
ATYR
$543M
| $63.8K | ﹤0.01% |
+21,126
| New | +$63.8K |
|
352
Clover Health Investments
CLOV
$1.34B
| $62.4K | ﹤0.01% |
+17,381
| New | +$62.4K |
|
353
FedEx
FDX
$52.9B
| $56.1K | ﹤0.01% |
+230
| New | +$56.1K |
|
354
United States Antimony
UAMY
$531M
| $48.8K | ﹤0.01% |
+22,189
| New | +$48.8K |
|
355
Corvus Pharmaceuticals
CRVS
$422M
| $47K | ﹤0.01% |
+14,793
| New | +$47K |
|
356
Neuronetics
STIM
$213M
| $43.5K | ﹤0.01% |
+11,829
| New | +$43.5K |
|
357
Butterfly Network
BFLY
$378M
| $43.2K | ﹤0.01% |
+18,939
| New | +$43.2K |
|
358
Protalix BioTherapeutics
PLX
$130M
| $40.2K | ﹤0.01% |
+15,690
| New | +$40.2K |
|
359
Amylyx Pharmaceuticals
AMLX
$845M
| $38.9K | ﹤0.01% |
+10,980
| New | +$38.9K |
|
360
Douglas Elliman
DOUG
$233M
| $34.8K | ﹤0.01% |
+20,215
| New | +$34.8K |
|
361
Eledon Pharmaceuticals
ELDN
$153M
| $34.5K | ﹤0.01% |
+10,170
| New | +$34.5K |
|
362
Blue Ridge Bankshares
BRBS
$365M
| $33.3K | ﹤0.01% |
+10,229
| New | +$33.3K |
|
363
Expensify
EXFY
$175M
| $31.8K | ﹤0.01% |
+10,475
| New | +$31.8K |
|
364
Mercado Libre
MELI
$121B
| $27.3K | ﹤0.01% |
14
-206
| -94% | -$402K |
|
365
loanDepot
LDI
$412M
| $27.3K | ﹤0.01% |
+22,935
| New | +$27.3K |
|
366
Origin Materials
ORGN
$80M
| $26.6K | ﹤0.01% |
+40,098
| New | +$26.6K |
|
367
Gevo
GEVO
$409M
| $25.5K | ﹤0.01% |
+21,995
| New | +$25.5K |
|
368
Aclaris Therapeutics
ACRS
$217M
| $23.9K | ﹤0.01% |
+15,593
| New | +$23.9K |
|
369
Kopin
KOPN
$332M
| $21.2K | ﹤0.01% |
+22,727
| New | +$21.2K |
|
370
Plug Power
PLUG
$1.7B
| $17.9K | ﹤0.01% |
+13,284
| New | +$17.9K |
|
|
ILLR
371
Triller Group Inc. Common Stock
ILLR
$72.9M
| $16.1K | ﹤0.01% |
+20,661
| New | +$16.1K |
|
372
Sangamo Therapeutics
SGMO
$162M
| $10.3K | ﹤0.01% |
+15,690
| New | +$10.3K |
|
373
Snap
SNAP
$11.8B
| $7.56K | ﹤0.01% |
+868
| New | +$7.56K |
|
374
RH
RH
$4.16B
| $7.5K | ﹤0.01% |
+32
| New | +$7.5K |
|
375
Assured Guaranty
AGO
$3.87B
| – | – |
-3,320
| Closed | -$299K |
|